Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.

Abstract	The case histories of five patients initially resistant to Glucantime therapy are presented. In addition comments are made on each patient since they demonstrated unusual clinical features. The practical difficulties in assessing true resistance to Glucantime are briefly discussed.
Authors	R A Rocha, R N Sampaio, M Guerra, A Magalhâes, C C Cuba, A C Barreto, P D Marsden
Journal	The Journal of tropical medicine and hygiene (J Trop Med Hyg) Vol. 83 Issue 4 Pg. 131-9 (Aug 1980) ISSN: 0022-5304 [Print] England
PMID	6997505 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References	Antigens Organometallic Compounds Sorbitol Meglumine Meglumine Antimoniate Amphotericin B Antimony
Topics	Amphotericin B (adverse effects, therapeutic use) Antigens (immunology) Antimony (therapeutic use) Brazil Female Fluorescent Antibody Technique Humans Leishmania (immunology) Leishmaniasis, Mucocutaneous (drug therapy, immunology) Meglumine (therapeutic use) Meglumine Antimoniate Middle Aged Organometallic Compounds Sorbitol (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!